Has Keith Kerr, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,250 in general payments to Keith Kerr, MD across 34 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Keith Kerr, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Keith Kerr, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Keith Kerr, MD

Neurological Surgery · Cypress, TXNPI 1659715316

Payments from drug & device makers

$4,250in general payments, 2019–2025

Across 34 payments — averaging $124.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$3K
Globus Medical$980
Medtronic$217
Alphatec Spine, Inc$180
Omniscient Neurotechnology America Ltd$138
Orthofix Medical, Inc.$107
plus $54 from 2 others

What the payments were for

Travel & lodging$2,33555%
Food & beverage$1,91445%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	18	$2,574
Globus Medical	4	$980
Medtronic(2 entities)	4	$217
Alphatec Spine, Inc	1	$180
Omniscient Neurotechnology America Ltd	4	$138
Orthofix Medical, Inc.	1	$107
Si-bone, Inc.	1	$37
Novartis	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,250 in reported general payments places this provider in the 50th percentile of 582 neurological surgery providers in Texas.

See all neurological surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$58,876

Medicare patients

107

Services billed

191

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Methocarbamol	40	$468
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	24	$226
Tizanidine Hcl	16	$212
Gabapentin	42	$189
Meloxicam	17	$86

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Cypress

John DormanOdessa$8.5M
Daniel PetersonAustin$5.8M
Daniel CurryHouston$3M
Peter KanGalveston$1.8M
Mirza BaigShenandoah$1.6M
Koijan KainthThe Woodlands$1.3M
Luis DuarteSan Angelo$1.2M
Douglas FoxAustin$948K
Richard MeyratDallas$883K
Adam LewisCorpus Christi$851K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →